These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 38032391

  • 1. Serotonin syndrome: A pharmacovigilance comparative study of drugs affecting serotonin levels.
    Elli C, Novella A, Pasina L.
    Eur J Clin Pharmacol; 2024 Feb; 80(2):231-237. PubMed ID: 38032391
    [Abstract] [Full Text] [Related]

  • 2. Association of Hyponatraemia and Antidepressant Drugs: A Pharmacovigilance-Pharmacodynamic Assessment Through an Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
    Mazhar F, Pozzi M, Gentili M, Scatigna M, Clementi E, Radice S, Carnovale C.
    CNS Drugs; 2019 Jun; 33(6):581-592. PubMed ID: 30977109
    [Abstract] [Full Text] [Related]

  • 3. Serotonin syndrome by drug interactions with linezolid: clues from pharmacovigilance-pharmacokinetic/pharmacodynamic analysis.
    Gatti M, Raschi E, De Ponti F.
    Eur J Clin Pharmacol; 2021 Feb; 77(2):233-239. PubMed ID: 32901348
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Serotonin Syndrome: Analysis of Cases Registered in the French Pharmacovigilance Database.
    Abadie D, Rousseau V, Logerot S, Cottin J, Montastruc JL, Montastruc F.
    J Clin Psychopharmacol; 2015 Aug; 35(4):382-8. PubMed ID: 26082973
    [Abstract] [Full Text] [Related]

  • 7. Linezolid and serotonergic drug interactions: a retrospective survey.
    Taylor JJ, Wilson JW, Estes LL.
    Clin Infect Dis; 2006 Jul 15; 43(2):180-7. PubMed ID: 16779744
    [Abstract] [Full Text] [Related]

  • 8. Serotonin toxicity associated with the use of linezolid: a review of postmarketing data.
    Lawrence KR, Adra M, Gillman PK.
    Clin Infect Dis; 2006 Jun 01; 42(11):1578-83. PubMed ID: 16652315
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database.
    Welch HK, Kellum JA, Kane-Gill SL.
    Pharmacotherapy; 2018 Aug 01; 38(8):785-793. PubMed ID: 29883524
    [Abstract] [Full Text] [Related]

  • 12. [Antidepressive agents and hypertension: A case/no-case study in French pharmacovigilance database].
    Hofferer A, Dolladille C, Chretien B, Sassier M, Laugier D, Atzenhoffer M, Bagheri H, Alexandre J, Fedrizzi S, Humbert X.
    Encephale; 2022 Aug 01; 48(4):404-408. PubMed ID: 34311965
    [Abstract] [Full Text] [Related]

  • 13. Fluid retention-associated adverse events in patients treated with BCR::ABL1 inhibitors based on FDA Adverse Event Reporting System (FAERS): a retrospective pharmacovigilance study.
    Huang J, Cai J, Ye Q, Jiang Q, Lin H, Wu L.
    BMJ Open; 2023 Aug 03; 13(8):e071456. PubMed ID: 37536976
    [Abstract] [Full Text] [Related]

  • 14. Incidence of Serotonin Syndrome With Combined Use of Linezolid and Serotonin Reuptake Inhibitors Compared With Linezolid Monotherapy.
    Karkow DC, Kauer JF, Ernst EJ.
    J Clin Psychopharmacol; 2017 Oct 03; 37(5):518-523. PubMed ID: 28796019
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database.
    Revet A, Montastruc F, Roussin A, Raynaud JP, Lapeyre-Mestre M, Nguyen TTH.
    BMC Psychiatry; 2020 Jun 16; 20(1):308. PubMed ID: 32546134
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Association of Coprescription of Triptan Antimigraine Drugs and Selective Serotonin Reuptake Inhibitor or Selective Norepinephrine Reuptake Inhibitor Antidepressants With Serotonin Syndrome.
    Orlova Y, Rizzoli P, Loder E.
    JAMA Neurol; 2018 May 01; 75(5):566-572. PubMed ID: 29482205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.